Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Filings indexed 3,174 across all filing types
Latest filing 2024-09-26 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, related to the loss of share certificate details from a shareholder. It is addressed to stock exchanges and signed by the company secretary. The content is a regulatory compliance communication about share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or report results but is a regulatory filing to comply with listing obligations. The document length is short (2623 characters) and it is a formal certificate rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2024-09-26 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details from a shareholder. It is addressed to stock exchanges and signed by the company secretary. The content is a regulatory compliance filing related to share certificate loss, not a financial report, management change, or voting result. It does not contain financial data or report results but is a regulatory compliance document. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and focused on compliance, not a report publication announcement or other categories.
2024-09-26 English
Intimation of Trading Window Closure period.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations and the company's code of conduct. It mentions the upcoming declaration of unaudited financial results for the quarter ending September 30, 2024, but does not contain any financial data or results itself. The document is short (1909 characters) and serves as an announcement related to insider trading restrictions ahead of financial results. It does not contain the financial report or detailed data, nor is it a certification or legal proceeding. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-09-25 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details received from a shareholder. It is a regulatory compliance communication to stock exchanges, signed by the company secretary. The document does not contain financial statements, management discussion, or any report data. It is a regulatory filing related to share certificate loss compliance, not a financial report or announcement of voting results, capital changes, or management changes. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal compliance certificate, not a report or announcement of a report publication.
2024-09-25 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations and the company's code of conduct. It mentions the upcoming declaration of unaudited financial results for the quarter ending September 30, 2024, but does not contain any financial data or results itself. The document is short (1909 characters) and serves as an announcement related to insider trading restrictions ahead of financial results. It does not contain the financial report or detailed data, nor is it a certification or legal proceeding. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-09-25 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details from a shareholder. It is a regulatory compliance filing related to share certificate loss, not a financial report, management change, or voting result. The document is short (2637 characters) and serves as a formal notification to stock exchanges. It does not contain financial data, management discussion, or meeting materials. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.